Friday, April 24, 2015 12:57:25 AM
"exciting potential new partnerships on the horizon"
"I strongly believe in the Company's prospects and business opportunities that lie ahead," stated Silverman
Purchase Collectively More Than 11 Million Shares of the Company's Stock at Market Price
http://finance.yahoo.com/news/veriteqs-chairman-ceo-scott-r-123000340.html
ABOUT
VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time. For more information on VeriTeQ, please visit www.veriteqcorp.com.
"I strongly believe in the Company's prospects and business opportunities that lie ahead," stated Silverman
Purchase Collectively More Than 11 Million Shares of the Company's Stock at Market Price
http://finance.yahoo.com/news/veriteqs-chairman-ceo-scott-r-123000340.html
ABOUT
VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time. For more information on VeriTeQ, please visit www.veriteqcorp.com.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
